Collplant Biotechnologies
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $108 | $73 | $60 | $77 |
Gross Profit | -653 | -243 | -348 | -415 |
EBITDA | -2,436 | -2,887 | -2,934 | -3,260 |
EBIT | -2,633 | -3,097 | -3,150 | -3,483 |
Net Income | -2,726 | -3,097 | -3,207 | -3,483 |
Net Change In Cash | 108 | 73 | 60 | 77 |
Free Cash Flow | -2,542 | -3,055 | -3,226 | -2,877 |
Cash | 2,951 | 4,262 | 5,950 | 8,547 |
Basic Shares | 1,442 | 1,374 | 1,280 | 1,272 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,371 | $515 | $10,959 | $299 |
Gross Profit | 624 | -2,148 | 7,866 | -1,177 |
EBITDA | -10,562 | -15,554 | -5,907 | -15,815 |
EBIT | -11,474 | -16,592 | -7,009 | -16,891 |
Net Income | -11,489 | -16,609 | -7,019 | -16,925 |
Net Change In Cash | 2,371 | 515 | 10,959 | 299 |
Free Cash Flow | -9,447 | -14,576 | -3,716 | -14,972 |
Cash | 5,950 | 11,909 | 26,674 | 29,653 |
Basic Shares | 1,220 | 1,145 | 1,138 | 1,103 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$1.88 |
2026-06-30 | -$1.89 |
2026-03-31 | -$0.22 |
2025-12-31 | -$0.25 |